Appili Therapeutics Inc.
APLIF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,363 | $2,276 | $4,309 | $4,883 |
| - Cash | $349 | $1,125 | $1,228 | $186 |
| + Debt | $12,223 | $12,352 | $12,294 | $11,284 |
| Enterprise Value | $14,237 | $13,503 | $15,375 | $15,981 |
| Revenue | $104 | $0 | -$13 | $108 |
| % Growth | – | 100% | -111.6% | – |
| Gross Profit | $104 | $0 | -$13 | $108 |
| % Margin | 100% | – | 100% | 100% |
| EBITDA | -$1,072 | -$729 | $928 | -$8 |
| % Margin | -1,031.7% | – | -7,365.1% | -7.6% |
| Net Income | -$989 | -$1,250 | $228 | -$524 |
| % Margin | -951.6% | – | -1,809.1% | -483.9% |
| EPS Diluted | -0.01 | -0.01 | 0.002 | -0.004 |
| % Growth | 2.9% | -642.1% | 144.2% | – |
| Operating Cash Flow | -$759 | -$6 | $1,034 | -$442 |
| Capital Expenditures | $0 | $0 | $0 | -$1 |
| Free Cash Flow | -$759 | -$6 | $1,034 | -$443 |